“Effectiveness and Safety of First-Generation Protease Inhibitors in Real-World Patients With Hepatitis C Virus Genotype 1 Infection in Brazil: A Multicenter Study”. Clinics, vol. 72, no. 6, June 2017, pp. 378-85, https://doi.org/10.6061/clinics/2017(06)08.